➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
McKinsey
Express Scripts
Harvard Business School
Moodys

Last Updated: July 4, 2020

DrugPatentWatch Database Preview

ENOXAPARIN SODIUM (PRESERVATIVE FREE) Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Enoxaparin Sodium (preservative Free), and what generic alternatives are available?

Enoxaparin Sodium (preservative Free) is a drug marketed by Amphastar Pharm, Apotex Inc, Nanjing King-friend, Sandoz, and Teva. and is included in five NDAs.

The generic ingredient in ENOXAPARIN SODIUM (PRESERVATIVE FREE) is enoxaparin sodium. There are thirteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the enoxaparin sodium profile page.

US ANDA Litigation and Generic Entry Outlook for Enoxaparin Sodium (preservative Free)

A generic version of ENOXAPARIN SODIUM (PRESERVATIVE FREE) was approved as enoxaparin sodium by SANDOZ INC on November 28th, 2011.

  Start Trial

Summary for ENOXAPARIN SODIUM (PRESERVATIVE FREE)
Drug patent expirations by year for ENOXAPARIN SODIUM (PRESERVATIVE FREE)
Pharmacology for ENOXAPARIN SODIUM (PRESERVATIVE FREE)

US Patents and Regulatory Information for ENOXAPARIN SODIUM (PRESERVATIVE FREE)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 076726-004 Jun 23, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Sandoz ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 077857-007 Jul 23, 2010 AP RX No No   Start Trial   Start Trial   Start Trial
Teva ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 076726-005 Jun 23, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Teva ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 076726-001 Jun 23, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Amphastar Pharm ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 076684-001 Sep 19, 2011 AP RX No No   Start Trial   Start Trial   Start Trial
Nanjing King-friend ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 206834-004 Nov 29, 2019 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
McKinsey
Express Scripts
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.